Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204 In light of evolving ...

Journal of Nuclear Medicine January 2025, jnumed.124.268233; DOI: https://doi.org/10.2967/jnumed.124.268233 ...

Viridans group streptococci (VGS) comprise five categories of microorganisms that are part of the human microbiome. They are usually found in oropharynx and in gastrointestinal and genitourinary ...

Neratinib is under clinical development by Puma Biotechnology and currently in Phase II for Ocular Melanoma. According to GlobalData, Phase II drugs for Ocular Melanoma have a 28% phase transition ...

The FDA approved tislelizumab plus chemotherapy for the first-line treatment of unresectable or metastatic gastric or GEJ adenocarcinoma. The FDA has approved tislelizumab-jsgr (Tevimbra) for use with ...